Latest

Latest immunotherapy News | Page 3

  • Latest immunotherapy news stories and updates. What is happening today? All recent immunotherapy news and developments. Live coverage and timeline of immunotherapy. All you need to know about immunotherapy.
Mater Researcher’s lymphoma studies attract funding boost
Ludwig Lausanne study illuminates a potentially exploitable coordination of gene expression across the tumor microenvironment
Vital boost to blood cancer treatment
Is it Allergies or Something Else?
Daffodil Day appeal is raising much needed funds
HaemaLogiX and Peter MacCallum Cancer Centre Announce Myeloma CAR-T Phase I Clinical Trial Agreement
World-first clinical trial for blood cancer underway in the Illawarra
Immune cells in single file
International collaboration to fund breakthrough research to shape the future of precision medicine
Gaining insight into the potential of cannabis in combating viral infections
Donation allows scientists to explore asbestos treatments
Capivasertib in combination with Faslodex granted Priority Review in the US for patients with advanced HR-positive breast cancer
Ludwig Cancer Research study shows certain blood pressure drugs could boost the efficacy of cancer immunotherapy
Datopotamab deruxtecan combinations showed encouraging tumour responses in patients with advanced non-small cell lung cancer in TROPION-Lung02 Phase Ib trial
Lynparza and Imfinzi combination reduced risk of disease progression or death by 37% vs. chemotherapy and bevacizumab in patients with advanced ovarian…
Memory killer cells can improve survival for melanoma patients
Improving Immune Checkpoint Inhibitors’ Anti-tumor Response and Minimizing Side Effects
Life Now participant finds mental and physical benefit from exercising during cancer treatment
Ludwig Chicago study identifies potentially new strategy for combination radio- and immunotherapy
Imfinzi plus Lynparza and Imfinzi alone both significantly improved progression-free survival in advanced endometrial cancer when added to chemotherapy
AstraZeneca will highlight momentum of practice-changing cancer medicines across its robust pipeline at ASCO 2023
Supercharged brain cancer treatment advances to clinical trial
Four common palliative care myths 23 May
Ludwig Oxford’s Yang Shi elected to the Academy of Medical Sciences
Positive results for Immutep’s cancer candidate in combination with MSD’s Keytruda
CAR-NKT cell therapy shows promising results against neuroblastoma in phase 1 clinical trial
Mater Research Celebrates International Nurses Day
SAiGENCI recruit recognised with prestigious award
Funding boost advances research on cancer vaccine
Advanced immunotherapy treatment may hold promise for children with brain cancer
Breast cancer tumors disrupt the immune system remotely favoring their own growth
Merriwa champion becomes face of new cancer research appeal
First patient on trial in colorectal, gastric and ovarian cancer study
Two Ludwig Cancer Research scientists named Fellows of the American Association for Cancer Research
Ludwig Cancer Research scientists to present at AACR Annual Meeting
Surprise finding shows neutrophils can fight tumors
International partnership launches Monash University-Helmholtz lab to solve global oncology, cardiology and infectious disease challenges
Top talent to boost cancer research
Immutep announces initiation of new breast cancer trial
Exposing tumours to bacteria converts immune cells to cancer killers
Exposing cancers to bacteria reminds first responder immune
Running buddies step up for breast cancer survivor Sarah
When it comes to food allergies, trust your gut
Baylor receives more than $5.8 million in CPRIT funding
Genetic study: Unexpectedly high variation in T-cell receptor genes between persons
Major genetic study reveals unexpectedly high variation in T-cell receptor genes between persons
‘Natural killer’ immune cells can modify tissue inflammation: study
Immutep reaches enrolment target for INSIGHT-003 trial in first line NSCLC

© 2024 - The National Tribune Australia